Morphological characteristics of the posterior neck muscles and anatomical landmarks for botulinum toxin injections.
Botulinum toxin
Cervical dystonia
Muscle thickness
Posterior neck muscles
Journal
Surgical and radiologic anatomy : SRA
ISSN: 1279-8517
Titre abrégé: Surg Radiol Anat
Pays: Germany
ID NLM: 8608029
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
03
01
2021
accepted:
29
03
2021
pubmed:
14
4
2021
medline:
10
9
2021
entrez:
13
4
2021
Statut:
ppublish
Résumé
Cervical dystonia is a common movement disorder for which botulinum toxin (BoNT) is the first choice treatment. Injecting the specific neck muscles can be challenging because of their thin morphology and deep locations. We, therefore, designed a study to investigate the locations of the posterior neck muscles to help the physician predict the locations of the targeted neck muscles and to protect the vertebral vessels from injury during deep injections. The posterior neck region was divided into four quadrants by imaginary lines passing vertically and transversely through the spinous process of C2 vertebra (C2 2 cm above the C2 Although BoNT injection into the posterior neck muscles is challenging, we think that it can be practically and safely applied using the measurements obtained in this study.
Identifiants
pubmed: 33847773
doi: 10.1007/s00276-021-02745-2
pii: 10.1007/s00276-021-02745-2
doi:
Substances chimiques
Botulinum Toxins
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1235-1242Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.
Références
Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, Gasser T, Krauss JK, Nardocci N, Newton A, Valls-Sole J (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18:5–18. https://doi.org/10.1111/j.1468-1331.2010.03042.x
doi: 10.1111/j.1468-1331.2010.03042.x
pubmed: 20482602
Apaydin N, Uz A, Evirgen O, Loukas M, Tubbs RS, Elhan A (2008) The phrenico-esophageal ligament: an anatomical study. Surg Radiol Anat 30:29–36. https://doi.org/10.1007/s00276-007-0279-0
doi: 10.1007/s00276-007-0279-0
pubmed: 18058057
Bae JH, Lee JS, Choi DY, Suhk J, Kim ST (2018) Accessory nerve distribution for aesthetic botulinum toxin injections into the upper trapezius muscle: anatomical study and clinical trial: reproducible BoNT injection sites for upper trapezius. Surg Radiol Anat 40:1253–1259. https://doi.org/10.1007/s00276-018-2059-4
doi: 10.1007/s00276-018-2059-4
pubmed: 29946827
Bhidayasiri R (2011) Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses. Park Rel Disord 17(Suppl 1):20–24. https://doi.org/10.1016/j.parkreldis.2011.06.015
doi: 10.1016/j.parkreldis.2011.06.015
Brumpt E, Aubry S, Vuillier F, Tatu L (2021) Anatomo-sonographic identification of the longissimus capitis and splenius cervicis muscles: principles for possible application to ultrasound-guided botulinum toxin injections in cervical dystonia. Surg Radiol Anat. https://doi.org/10.1007/s00276-020-02646-w
doi: 10.1007/s00276-020-02646-w
pubmed: 33459837
pmcid: 8164608
Chan J, Brin MF, Fahn S (1991) Idiopathic cervical dystonia: clinical characteristics. Mov Disord 6:119–126. https://doi.org/10.1002/mds.870060206
doi: 10.1002/mds.870060206
pubmed: 2057004
Colosimo C, Charles D, Misra VP, Maisonobe P, Om S (2019) How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study. J Neurol 266:3038–3046. https://doi.org/10.1007/s00415-019-09527-2
doi: 10.1007/s00415-019-09527-2
pubmed: 31501975
pmcid: 6851034
Comella C, Bhatia K (2015) An international survey of patients with cervical dystonia. J Neurol 262:837–848. https://doi.org/10.1007/s00415-014-7586-2
doi: 10.1007/s00415-014-7586-2
pubmed: 25605434
pmcid: 4544552
Comella CL (2002) Cervical dystonia: treatment with botulinum toxin serotype A as Botox or Dysport. In: Brin MF, Hallett M, Jankovic J (eds) Scientific and therapeutic aspects of botulinum toxin, 1st edn. Lippincott Williams and Wilkins, Philadelphia, pp 359–364
Comella CL, Brin MF, Jankovic J (2000) Botulinum toxin in the clinical management of cervical dystonia. Neurol 55:1–15
doi: 10.1212/WNL.55.1.1
Delnooz CC, Veugen LC, Pasman JW, Lapatki BG, van Dijk JP, van de Warrenburg BP (2014) The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia. Eur J Neurol 21:1486-e1498. https://doi.org/10.1111/ene.12517
doi: 10.1111/ene.12517
pubmed: 25060697
Ernst MJ, Sommer BB, Meichtry A, Bauer CM (2019) Intra-rater reliability of determining positions of cervical spinous processes and measuring their relative distances: An update to define rigid bodies of the cervical spine in a movement laboratory setting. BMC Res Notes 12:265. https://doi.org/10.1186/s13104-019-4299-8
doi: 10.1186/s13104-019-4299-8
pubmed: 31088571
pmcid: 6515637
Fahn S, Marsden CD, Calne DB (1987) Classification and investigation of dystonia. Mov Disord 2:332–358
Hallgren RC, Andary MT, Wyman AJ, Rowan JJ (2008) A standardized protocol for needle placement in suboccipital muscles. Clin Anat 21:501–508. https://doi.org/10.1002/ca.20660
doi: 10.1002/ca.20660
pubmed: 18627103
Hong JS, Sathe GG, Niyonkuru C, Munin MC (2012) Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia. Muscle Nerve 46:535–539. https://doi.org/10.1002/mus.23409
doi: 10.1002/mus.23409
pubmed: 22987694
Jahanshahi M, Marsden CD (1990) Body concept, disability, and depression in patients with spasmodic torticollis. Behav Neurol 3:117–131
doi: 10.1155/1990/764203
Jost WH, Biering-Sørensen B, Drużdż A, Kreisler A, Pandey S, Sławek J, Tatu L (2020) Preferred muscles in cervical dystonia. Neurol Neurochir Pol 54:277–279. https://doi.org/10.5603/PJNNS.a2020.0022
doi: 10.5603/PJNNS.a2020.0022
pubmed: 32227332
Jost WH, Tatu L, Pandey S, Slawek J, Druzdz A, Biering-Sorensen B, Altmann CF, Kreisler A (2020) Frequency of different subtypes of cervical dystonia: a prospective multicenter study according to Col-Cap concept. J Neural Transm 127:45–50. https://doi.org/10.1007/s00702-019-02116-7
doi: 10.1007/s00702-019-02116-7
pubmed: 31828512
Ko YD, Yun SI, Ryoo D, Chung ME, Park J (2020) Accuracy of ultrasound-guided and non-guided botulinum toxin injection into neck muscles involved in cervical dystonia: a cadaveric study. Ann Rehabil Med 44:370–377. https://doi.org/10.5535/arm.19211
doi: 10.5535/arm.19211
pubmed: 32986942
pmcid: 7655231
Lee JH, Lee BN, Han SH, An XC, Chung RH (2011) The effective zone of botulinum toxin A injections in the sternocleidomastoid muscle. Surg Radiol Anat 33:185–190. https://doi.org/10.1007/s00276-010-0729-y
doi: 10.1007/s00276-010-0729-y
pubmed: 20886338
Liu W-M, Chen Q, Liang Y, Bian C, Huang J-M, Dong J (2017) Surgical landmark of mandible angle in the identification of cervical spinal level. J Craniofac Surg 28:1582–1585. https://doi.org/10.1097/scs.0000000000003703
doi: 10.1097/scs.0000000000003703
pubmed: 28863109
Loukas M, Louis RG Jr, Childs RS (2006) Anatomical examination of the recurrent artery of Heubner. Clin Anat 19:25–31. https://doi.org/10.1002/ca.20229
doi: 10.1002/ca.20229
pubmed: 16287124
Mayer NH, Whyte J, Wannstedt G, Ellis CA (2008) Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. Arch Phys Med Rehabil 89:982–987. https://doi.org/10.1016/j.apmr.2007.10.022
doi: 10.1016/j.apmr.2007.10.022
pubmed: 18452749
Mayoux-Benhamou MA, Revel M, Vallee C (1995) Surface electrodes are not appropriate to record selective myoelectric activity of splenius capitis muscle in humans. Exp Brain Res 105:432–438
Mayoux-Benhamou MA, Revel M, Wybier M, Barbet JP (1995) Computerized tomographical study of dorsal neck muscles for insertion of EMG wire electrodes. J Electromyogr Kinesiol 5:101–107
doi: 10.1016/1050-6411(94)00010-J
Mejia NI, Vuong KD, Jankovic J (2005) Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 20:592–597. https://doi.org/10.1002/mds.20376
doi: 10.1002/mds.20376
pubmed: 15645481
Muller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J, Diez J, Homann N, Wenning GK, Schnider P, Poewe W, Austrian Botulinum Toxin Dystonia Study Group (2002) The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 249:842–846. https://doi.org/10.1007/s00415-002-0733-1
doi: 10.1007/s00415-002-0733-1
pubmed: 12140667
Pfister J, Zenker W (1984) The splenius capitis muscle of the rat, architecture and histochemistry, afferent and efferent innervation as compared with that of the quadriceps muscle. Anat Embryol 169:79–89
doi: 10.1007/BF00300589
Poewe W, Burbaud P, Castelnovo G, Jost WH, Ceballos-Baumann AO, Banach M, Potulska-Chromik A, Ferreira JJ, Bihari K, Ehler E, Bares M, Dzyak LA, Belova AN, Pham E, Liu WJ, Picaut P (2016) Efficacy and safety of abobotulinumtoxin A liquid formulation in cervical dystonia: a randomized-controlled trial. Mov Disord 31:1649–1657. https://doi.org/10.1002/mds.26760
doi: 10.1002/mds.26760
pubmed: 27653448
Schwartz MFB (2002) Botulinum toxin A therapy for temporomandibular disorders. In: Brin MF, Hallett M, Jankovic J (eds) Scientific and therapeutic aspects of botulinum toxin, 1st edn. Lippincott Williams and Wilkins, Philadelphia, p 259
Scott AB (2002) The role of botulinum toxin type A in the management of strabismus. In: Brin MF, Hallett M, Jankovic J (eds) Scientific and therapeutic aspects of botulinum toxin, 1st edn. Lippincott Williams & Wilkins, Philadelphia, pp 189–195
Shaari CM, George E, Wu BL, Biller HF, Sanders I (1991) Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 101:960–964
doi: 10.1288/00005537-199109000-00006
Shaari CM, Sander I (1993) Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 16:964–969
doi: 10.1002/mus.880160913
Shiraishi M, Masuda T, Sadoyama T, Okada M (1995) Innervation zones in the back muscles investigated by multichannel surface EMG. J Electromyogr Kinesiol 5:161–167
doi: 10.1016/1050-6411(95)00002-H
Tatu L, Jost WH (2017) Anatomy and cervical dystonia: “Dysfunction follows form.” J Neural Transm 124:237–243. https://doi.org/10.1007/s00702-016-1621-7
doi: 10.1007/s00702-016-1621-7
pubmed: 27624726
Tintner RJJ (2002) Botulinum toxin type A in the management of oromandibular dystonia and bruxism. In: Brin MF, Hallett M, Jankovic J (eds) Scientific and therapeutic aspects of botulinum toxin, 1st edn. Lippincott Williams and Wilkins, Philadelphia, pp 343–350
Torun BI, Kendir S, Uz A (2017) Standardization of sternocleidomastoid for botulinum toxin applications. Anatomy 11:128–132. https://doi.org/10.2399/ana.17.039
doi: 10.2399/ana.17.039
Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S, Global Dysport Cervical Dystonia Study Group (2010) Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Park Rel Disord 16:316–323. https://doi.org/10.1016/j.parkreldis.2010.03.002
doi: 10.1016/j.parkreldis.2010.03.002
Tsui JK, Eisen A, Mak E, Carruthers J, Scott A, Calne DB (1985) A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 12:314–316. https://doi.org/10.1017/s031716710003540x
doi: 10.1017/s031716710003540x
pubmed: 4084867